BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Angiogenesis
,
Arthritis
,
Embryo
,
Pharmacogenetics
,
Doxorubicin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
2-chlorodeoxyadenosine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CEP192
HIST1H3J
RPLP0
TWSG1
HIST1H2BB
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FISCHER_DREAM_TARGETS
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
nucleoplasm
MARSON_BOUND_BY_E2F4_UNSTIMULATED
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
PBMCs of T-cell prolymphocytic leukemia patients pre- and post- alemtuzumab and cladribine treatment
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Breast adenocarcinoma MCF7 cells treated with various environmental chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with c…
A new synthesis of 2-chloro-2'-deoxyadenosine (Cladribine), CdA).
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis.
Cladribine as a therapeutic option in multiple sclerosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V6…
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosin…
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leuk…
Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ